Budakeszi, Hungary

Gyula Beke

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gyula Beke: Innovator in Pharmaceutical Chemistry

Introduction

Gyula Beke is a notable inventor based in Budakeszi, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding three patents that reflect his innovative spirit and dedication to advancing medical science.

Latest Patents

One of his latest patents involves indole derivatives. This invention relates to compounds of the general form (I) and includes new substituted diazepino-indole derivatives, as well as pharmaceutically acceptable salts and compositions. These compounds are particularly relevant for the treatment or prevention of disorders associated with melanin-concentrating hormone receptor 1 activity. Another significant patent focuses on benzamide derivatives as bradykinin antagonists. This invention pertains to new phenylsulfamoyl benzamide derivatives of formula (I), showcasing his expertise in developing novel therapeutic agents.

Career Highlights

Gyula Beke has worked with prominent companies in the pharmaceutical industry, including Richter Gedeon Nyrt. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the development of new medications and treatments.

Collaborations

Throughout his career, Gyula has collaborated with talented individuals such as Eva Bozo and Sandor Farkas. These partnerships have fostered a creative environment that encourages the exchange of ideas and the advancement of research.

Conclusion

Gyula Beke's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…